NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/18/2026
Back to search
Official data from USPTO
AUROBAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/19/2026
Trademark type
Word
Nice classes
5, 42
Filing date
06/15/2023
Registration date
10/08/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/08/2024
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
PHILLIPS, ALEXANDER J
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
AUROBAC THERAPEUTICS SAS
Representatives
Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary productsnamely pharmaceutical and veterinary preparations for prevention and treatment of infectious diseases and critical care conditionssystemic inflammatory response syndrome (SIRS)sepsisseptic shockas well as related diseases and co-morbidities; dietetic food and dietetic substances being preparations for medical or veterinary use
Class 42
Scientific and technological servicespharmaceutical drug development services as well as research and design services relating thereto; industrial analysis and research servicesresearch and development of new products for third parties; medical research services; research services in the fields of biologybacteriologychemistry; clinical research in the field of infectious diseases and critical care; Scientific research in the nature of conducting clinical trials for others; development of pharmaceutical products
Publications
History of USPTO decisions and trademark events.
37 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/19/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/19/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/19/2025
FIMP
FINAL DISPOSITION PROCESSED
03/19/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/17/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/08/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2024
PUBO
PUBLISHED FOR OPPOSITION
07/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/14/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/14/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/14/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2024
RFNT
REFUSAL PROCESSED BY IB
04/23/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/30/2024
RFRR
REFUSAL PROCESSED BY MPU
03/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2024
CNRT
NON-FINAL ACTION WRITTEN
03/11/2024
DOCK
ASSIGNED TO EXAMINER
03/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/04/2023
Continuous trademark protection
Get notified about every new filing that threatens AUROBAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.